Hydrafacial LLC v. Medicreations LLC

District Court, D. Nevada·Decided February 28, 2025·No. 2:24-cv-00855·Unknown

Opinion

HYDRAFACIAL LLC, Plaintiff, Case No.: 2:24-cv-00855-GMN-MDC vs. ORDER GRANTING IN PART MEDICREATIONS LLC, DEFENDANT’S PARTIAL MOTION TO DISMISS Defendant. Pending before the Court is a Motion to Dismiss, (ECF No. 22), filed by Defendant Medicreations. Plaintiff Hydrafacial filed a Response, (ECF No. 23), to which Defendant filed a Reply, (ECF No. 24). For the reasons discussed below, the Court GRANTS in part the Partial Motion to Dismiss. This case arises out of Defendant’s alleged infringement on Plaintiff’s patents. (See generally First Am. Compl. (“FAC”), ECF No. 20). Plaintiff designs, manufactures, and sells skin resurfacing and rejuvenation systems, including microdermabrasion and hydradermabrasion systems. (Id. ¶¶ 8–9). Plaintiff has received several patents for its products, including the 12 at issue in this case, (the “Asserted Patents”). (Id. ¶¶ 10–23). The patents are divided into the “Ignon Patents,” which include the ʾ052, ʾ089, ʾ641, ʾ642, ʾ477, and ʾ287 Patents, and the “Shadduck Patents,” which include the ʾ591, ʾ120, ʾ886, ʾ716, ʾ513, and ʾ464 Patents. (Id. ¶¶ 22–23). The Shadduck Patents expired in August 2020, but Plaintiff alleges that Defendant’s infringement occurred while those patents were still in effect. (Id. ¶ 22). Defendant sources, advertises, and sells aesthetic medical devices, including devices that allegedly infringe on Plaintiff’s patents. (Id. ¶¶ 24–37). Plaintiff alleges that Defendant had actual knowledge of the Asserted Patents when it began making and selling the infringing products or else acted with willful blindness to its infringement. (Id. ¶¶ 38–43). On October 21, 2020, Plaintiff sent a letter to Defendant informing it of the ʾ052, ʾ089, ʾ641, and ʾ642 Patents, (collectively, “the Demand Letter Patents”), and Defendant’s alleged infringement of them. (Id. ¶ 44). Plaintiff brings 12 claims, Counts I-XII, for infringement of the 12 Asserted Patents. (Id. ¶¶ 53–146). Defendant moves to dismiss Counts II-VII in their entirety and Counts I and VIII-XII in part, pursuant to Rule 12(b)(6). (See generally Mot. Dismiss, ECF No. 22). Dismissal is appropriate under Rule 12(b)(6) where a pleader fails to state a claim upon which relief can be granted. Fed. R. Civ. P. 12(b)(6). A pleading must give fair notice of a legally cognizable claim and the grounds on which it rests, and although a court must take all factual allegations as true, legal conclusions couched as factual allegations are insufficient. Bell Atl. Corp. v. Twombly, 550 U.S. 544, 555 (2007). Accordingly, Rule 12(b)(6) requires “more than labels and conclusions, and a formulaic recitation of the elements of a cause of action will

not do.” Id. “To survive a motion to dismiss, a complaint must contain sufficient factual matter, accepted as true, to ‘state a claim to relief that is plausible on its face.’” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quoting Twombly, 550 U.S. at 570). “A claim has facial plausibility when the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Id. This standard “asks for more than a sheer possibility that a defendant has acted unlawfully.” Id. If the court grants a motion to dismiss for failure to state a claim, the court should grant leave to amend “unless it determines that the pleading could not possibly be cured by the allegation of other facts.” Lopez v. Smith, 203 F.3d 1122, 1130 (9th Cir. 2000) (quoting Doe v. United States, 58 F.3d 494, 497 (9th Cir. 1995)). Pursuant to Rule 15(a), the court should “freely” give leave to amend “when justice so requires,” and in the absence of a reason such as “undue delay, bad faith or dilatory motive on the part of the movant, repeated failure to cure deficiencies by amendments previously allowed, undue prejudice to the opposing party by virtue of allowance of the amendment, futility of the amendment, etc.” Foman v. Davis, 371 U.S. 178, 182 (1962). Defendant argues that Plaintiff had not pleaded compliance with the marking statute, actual notice of infringement, or willful and indirect infringement. (See generally Mot. Dismiss, ECF No. 22). The Court begins with Defendant’s marking statute argument. A. Compliance with the Marking Statute, 35 U.S.C. § 287(a) Defendant first moves to dismiss seven of Plaintiff’s infringement claims for failure to allege proper marking. (Id. 10:16–20). It argues that the FAC does not allege any form of compliance with section 287(a) for the ʾ120 Patent, ʾ886 Patent, ʾ464 Patent, ʾ641 Patent, ʾ642 Patent, ’477 Patent, or the ʾ287 Patent. (Id.). Section 287(a) limits a patentee’s ability to recover damages for infringement, stating, in relevant part:

Free access — add to your briefcase to read the full text and ask questions with AI

Hydrafacial LLC v. Medicreations LLC, (D. Nev. 2025).

Hydrafacial LLC v. Medicreations LLC (Hydrafacial LLC v. Medicreations LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Warsaw Orthopedic, Inc. v. Nuvasive, Inc.
824 F.3d 1344 (Federal Circuit, 2016)
The Science
5 U.S. 178 (Supreme Court, 1866)
Lopez v. Smith
203 F.3d 1122 (Ninth Circuit, 2000)
Safari Club International v. Salazar
709 F.3d 1 (D.C. Circuit, 2013)
Eon Corp. IP Holdings LLC v. FLO TV Inc.
802 F. Supp. 2d 527 (D. Delaware, 2011)